References

  1. 1 van Rooyen JM, Kruger HS, Huisman HW, Wissing MP, Margetts BM, Venter CS, et al. An epidemiological study of hypertension and its determinants in a population in transition: the THUSA study. J Hum Hypertens. 2000;14(12):779–87.
  2. 2 Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II. Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104(23):2855–64.
  3. 3 Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part I. General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001;104(22):2746–53.
  4. 4 Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015.
  5. 5 Mensah GA, Roth GA, Sampson UK, Moran AE, Feigin VL, Forouzanfar MH, et al. Mortality from cardiovascular diseases in sub-Saharan Africa, 1990–2013: a systematic analysis of data from the Global Burden of Disease Study 2013. Cardiovasc J Afr. 2015;26(2 Suppl 1):S6–S10.
  6. 6 Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne ML. Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet. 2008;372(9642):893–901.
  7. 7 Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31(6):719–27.
  8. 8 Stewart S, Carrington M, Pretorius S, Methusi P, Sliwa K. Standing at the crossroads between new and historically prevalent heart disease: effects of migration and socio-economic factors in the Heart of Soweto cohort study. Eur Heart J. 2011;32(4):492–9.
  9. 9 Dudas K, Lappas G, Stewart S, Rosengren A. Trends in out-of-hospital deaths due to coronary heart disease in Sweden (1991 to 2006). Circulation. 2011;123(1):46–52.
  10. 10 Hung J, Teng TH, Finn J, Knuiman M, Briffa T, Stewart S, et al. Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia. J Am Heart Assoc. 2013;2(5):e000172.
  11. 11 Teng TH, Hung J, Knuiman M, Stewart S, Arnolda L, Jacobs I, et al. Trends in long-term cardiovascular mortality and morbidity in men and women with heart failure of ischemic versus non-ischemic aetiology in Western Australia between 1990 and 2005. Int J Cardiol. 2012;158(3):405–10.
  12. 12 Zimmet PZ, Magliano DJ, Herman WH, Shaw JE. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2(1):56–64.
  13. 13 Owen N, Healy GN, Matthews CE, Dunstan DW. Too much sitting: the population health science of sedentary behavior. Exerc Sport Sci Rev. 2010;38(3):105–13.
  14. 14 Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation. 2009;119(4):515–23.
  15. 15 Stewart S, Ekman I, Ekman T, Oden A, Rosengren A. Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes. 2010;3(6):573–80.
  16. 16 Olsson LG, Swedberg K, Lappas G, Stewart S, Rosengren A. Trends in mortality after first hospitalization with atrial fibrillation diagnosis in Sweden 1987 to 2006. Int J Cardiol. 2013;170(1):75–80.
  17. 17 Olsson LG, Swedberg K, Lappas G, Stewart S, Rosengren A. Trends in stroke incidence after hospitalization for atrial fibrillation in Sweden 1987 to 2006. Int J Cardiol. 2013;167(3):733–8.
  18. 18 Lonn E, Bosch J, Teo KK, Pais P, Xavier D, Yusuf S. The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions. Circulation. 2010;122(20):2078–88.
  19. 19 Sytkowski PA, Kannel WB, D'Agostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham Heart Study. N Engl J Med. 1990;322(23):1635–41.
  20. 20 Oosthuizen W, Vorster HH, Kruger A, Venter CS, Kruger HS, de Ridder JH. Impact of urbanisation on serum lipid profiles: the THUSA survey. S Afr Med J. 2002;92(9):723–8.
  21. 21 Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Ojji D, et al. The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries. Arch Intern Med. 2012;172(18):1386–94.
  22. 22 Hamer M, von Kanel R, Reimann M, Malan NT, Schutte AE, Huisman HW, et al. Progression of cardiovascular risk factors in black Africans: 3 year follow up of the SABPA cohort study. Atherosclerosis. 2015;238(1):52–4.
  23. 23 Huisman HW, Schutte AE, Schutte R, van Rooyen JM, Fourie CM, Mels CM, et al. Exploring the link between cardiovascular reactivity and end-organ damage in African and Caucasian men: the SABPA study. Am J Hypertens. 2013;26(1):68–75.
  24. 24 Meyburgh D, Malan L, Van Rooyen JM, Potgieter JC. Cardiovascular, cortisol and coping responses in urban Africans: the SAPBA study. Cardiovasc J Afr. 2012;23(1):28–33.
  25. 25 Kruger HS, Venter CS, Vorster HH, Study T. Physical inactivity as a risk factor for cardiovascular disease in communities undergoing rural to urban transition: the THUSA study. Cardiovasc J S Afr. 2003;14(1):16–23.
  26. 26 Malan L, Malan NT, Wissing MP, Seedat YK. Coping with urbanization: a cardiometabolic risk? The THUSA study. Biol Psychol. 2008;79(3):323–8.
  27. 27 Peer N, Lombard C, Steyn K, Levitt N. High prevalence of metabolic syndrome in the Black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study. Eur J Prev Cardiol. 2015;22(8):1036–42.
  28. 28 Peer N, Steyn K, Lombard C, Gwebushe N, Levitt N. A high burden of hypertension in the urban black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study. PLoS One. 2013;8(11):e78567.
  29. 29 Peer N, Steyn K, Lombard C, Gaziano T, Levitt N. Alarming rise in prevalence of atherogenic dyslipidaemia in the black population of Cape Town: the Cardiovascular Risk in Black South Africans (CRIBSA) study. Eur J Prev Cardiol. 2014;21(12):1549–56.
  30. 30 Central Intelligence Agency. The World Factbook: Nigeria. Washington, DC: Central Intelligence Agency, 2015 [updated September 2015; accessed September 2015]. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/ni.html.
  31. 31 The World Bank. Nigeria Economic Report; No. 2. Washington, DC: World Bank Group, 2014.
  32. 32 Adedini SA, Odimegwu C, Bamiwuye O, Fadeyibi O, De Wet N. Barriers to accessing health care in Nigeria: implications for child survival. Glob Health Action. 2014;7:23499.
  33. 33 Danawi H, Ogbonna F. Impact of socioeconomic status and household structure on infant mortality rate in Abia State of Nigeria. Int J Childbirth Educ. 2014;29(4).
  34. 34 Umeh CA, Onyi SC. Case based rubella surveillance in Abia State, South East Nigeria, 2007–2011. PeerJ. 2014;2:e580.
  35. 35 Stewart S, Carrington MJ, Pretorius S, Ogah OS, Blauwet L, Antras-Ferry J, et al. Elevated risk factors but low burden of heart disease in urban African primary care patients: a fundamental role for primary prevention. Int J Cardiol. 2012;158(2):205–10.
  36. 36 Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D, et al. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study “Heart Awareness Days.” Int J Cardiol. 2009;132(2):233–9.
  37. 37 Okpechi IG, Chukwuonye, II, Tiffin N, Madukwe OO, Onyeonoro UU, Umeizudike TI, et al. Blood pressure gradients and cardiovascular risk factors in urban and rural populations in Abia State South Eastern Nigeria using the WHO STEPwise approach. PLoS One. 2013;8(9):e73403.
  38. 38 Stewart S, Sliwa K. Preventing CVD in resource-poor areas: perspectives from the 'real-world'. Nat Rev Cardiol. 2009;6(7):489–92.
  39. 39 Carrington MJ, Jennings GL, Stewart S. Pattern of blood pressure in Australian adults: results from a national blood pressure screening day of 13,825 adults. Int J Cardiol. 2010;145(3):461–7.
  40. 40 Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25(3):305–13.
  41. 41 Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract. 2007;77(3):471–8.
  42. 42 Alberts M, Urdal P, Steyn K, Stensvold I, Tverdal A, Nel JH, et al. Prevalence of cardiovascular diseases and associated risk factors in a rural black population of South Africa. Eur J Cardiovasc Prev Rehabil. 2005;12(4):347–54.
  43. 43 Peltzer K. Health behaviour among Black and White South Africans. J R Soc Promo Health. 2002;122(3):187–93.
  44. 44 Seedat YK, Mayet FGH, Latiff GH, Joubert G. Study of Risk-Factors Leading to Coronary Heart-Disease in Urban Zulus. J Human Hypertension. 1993;7(6):529–32.
  45. 45 Lyons JG, Sliwa K, Carrington MJ, Raal F, Pretorius S, Thienemann F, et al. Lower levels of high-density lipoprotein cholesterol in urban Africans presenting with communicable versus non-communicable forms of heart disease: the 'Heart of Soweto' hospital registry study. BMJ Open. 2014;4(7):e005069.
  46. 46 Lyons JG, Stewart S. Prevention: Convergent communicable and noncommunicable heart disease. Nat Rev Cardiol. 2012;9(1):12–4.
  47. 47 Sliwa K, Lyons JG, Carrington MJ, Lecour S, Marais AD, Raal FJ, et al. Different lipid profiles according to ethnicity in the Heart of Soweto study cohort of de novo presentations of heart disease. Cardiovasc J Afr. 2012;23(7):389–95.
  48. 48 The World Bank. World Development Indicators: Urban Population [dataset] 2013. Available from: http://data.worldbank.org/indicator/SP.URB.TOTL.IN.ZS/countries.
  49. 49 Addo J, Smeeth L, Leon DA. Hypertension in sub-saharan Africa: a systematic review. Hypertension. 2007;50(6):1012–8.
  50. 50 Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet. 2008;371(9616):915–22.
  51. 51 Xanthakis V, Larson MG, Wollert KC, Aragam J, Cheng S, Ho J, et al. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening. J Am Heart Assoc. 2013;2(6):e000399.
  52. 52 Stoica R, Heller EN, Bella JN. Point-of-care screening for left ventricular hypertrophy and concentric geometry using hand-held cardiac ultrasound in hypertensive patients. Am J Cardiovasc Dis. 2011;1(2):119–25.
  53. 53 Sliwa K, Lee GA, Carrington MJ, Obel P, Okreglicki A, Stewart S. Redefining the ECG in urban South Africans: electrocardiographic findings in heart disease-free Africans. Int J Cardiol. 2013;167(5):2204–9.
  54. 54 World Health Organization. 2008–2013 Action Plan for the Global Strategy for the Prevention and Control of Noncommunicable Diseases. Geneva: WHO, 2008.
  55. 55 World Health Organization. Noncommunicable disease country specific profiles. 2011.
  56. 56 World Health Organization. Non-communicable Diseases and Mental Health Cluster. WHO STEPS Surveillance Manual: The WHO STEPwise Approach to Chronic Disease Risk Factor Surveillance. Geneva: WHO, 2005.
  57. 57 Oladapo OO, Salako L, Sodiq OS, K., Adedapo K, Falase AO. A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey. Cardiovasc J Afr 2010;21:26–31.
  58. 58 Ulasi, II, Ijoma CK, Onwubere BJ, Arodiwe E, Onodugo O, Okafor C. High prevalence and low awareness of hypertension in a market population in Enugu, Nigeria. Int J Hypertens. 2011;2011:869675.
  59. 59 Dzudie A, Kengne AP, Muna WF, Ba H, Menanga A, Kouam Kouam C, et al. Prevalence, awareness, treatment and control of hypertension in a self-selected sub-Saharan African urban population: a cross-sectional study. BMJ Open. 2012;2(4).
  60. 60 Cooper R, Rotimi C, Ataman S, McGee D, Osotimehin B, Kadiri S, et al. The prevalence of hypertension in seven populations of west African origin. Am J Public Health. 1997;87(2):160–8.
  61. 61 Alwan A, Maclean DR, Riley LM, d'Espaignet ET, Mathers CD, Stevens GA, et al. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet. 2010;376(9755):1861–8.
  62. 62 Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health. 2005;4(1):2.
  63. 63 Reddy KS. Cardiovascular diseases in the developing countries: dimensions, determinants, dynamics and directions for public health action. Public Health Nutr. 2002;5(1A):231–7.
  64. 64 Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, et al. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation. 2005;112(23):3554–61.
  65. 65 Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353(9164):1547–57.
  66. 66 Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155–65.
  67. 67 Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164(19):2126–34.
  68. 68 Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362(7):590–9.
  69. 69 Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, Tolonen H, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000;355(9205):675–87.
  70. 70 Capewell S, MacIntyre K, Stewart S, Chalmers JW, Boyd J, Finlayson A, et al. Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986–95: a retrospective cohort study. Lancet. 2001;358(9289):1213–7.
  71. 71 Macintyre K, Stewart S, Chalmers J, Pell J, Finlayson A, Boyd J, et al. Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. BMJ. 2001;322(7295):1152–3.
  72. 72 Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999–1008.
  73. 73 Gillum RF. The epidemiology of cardiovascular disease in black Americans. N Engl J Med. 1996;335(21):1597–9.
  74. 74 Stewart S, Wilkinson D, Becker A, Askew D, Ntyintyane L, McMurray JJ, et al. Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study. Int J Cardiol. 2006;108(1):101–8.
  75. 75 Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370(9603):1929–38.
  76. 76 Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as the cause of left ventricular dilation in active rheumatic carditis. J Am Coll Cardiol. 1993;22(3):826–9.
  77. 77 von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.
  78. 78 Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31(6):719–27.
  79. 79 Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, et al. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation. 2008;118(23):2360–7.
  80. 80 Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58(6):1072–83.
  81. 81 Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, Massachusetts: John Wright, 1982.
  82. 82 Setel PW, Saker L, Unwin NC, Hemed Y, Whiting DR, Kitange H. Is it time to reassess the categorization of disease burdens in low–income countries? Am J Public Health. 2004;94(3):384–8.
  83. 83 Stewart S, Mocumbi AO, Carrington MJ, Pretorius S, Burton R, Sliwa K. A not-so-rare form of heart failure in urban black Africans: pathways to right heart failure in the Heart of Soweto Study cohort. Eur J Heart Fail. 2011;13(10):1070–7.
  84. 84 Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, et al. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study. Heart. 2010;96(23):1878–82.
  85. 85 Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167(5):1807–24.
  86. 86 Lip GY, Brechin CM, Lane DA. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest. 2012;142(6):1489–98.
  87. 87 Albert MA. Heart failure in the urban African enclave of Soweto: a case study of contemporary epidemiological transition in the developing world. Circulation. 2008;118(23):2323–5.
  88. 88 Brink AJ, Aalbers J. Strategies for heart disease in sub-Saharan Africa. Heart. 2009;95(19):1559–60.
  89. 89 Kruger R, Kruger HS, Macintyre UE. The determinants of overweight and obesity among 10- to 15-year-old schoolchildren in the North West Province, South Africa: the THUSA BANA (Transition and Health during Urbanisation of South Africans; BANA, children) study. Public Health Nutr. 2006;9(3):351–8.
  90. 90 Sridhar D, Batniji R. Misfinancing global health: a case for transparency in disbursements and decision making. Lancet. 2008;372(9644):1185–91.
  91. 91 World Health Organization. Sub-Saharan Africa AIDS Epidemic Update Regional Summary. Geneva, Switzerland: WHO, 2008.
  92. 92 Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005;112(23):3547–53.